An Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia Crisis

Simple item page
dc.contributor.authorEmmanuel Ifeanyi Obeagu
dc.contributor.authorByamungu Pahari Kagenderezo
dc.contributor.authorOnyekachi Splendid Uwakwe
dc.contributor.authorSarah Nakyeyune
dc.contributor.authorGetrude Uzoma Obeagu
dc.date.accessioned2024-07-22T14:13:38Z
dc.date.available2024-07-22T14:13:38Z
dc.date.issued2022
dc.description.abstractSickle cell disease has been described by many scholars as a chronic inflammatory disease which is linked to many factors such as endothelial destruction, increased synthesis of reactive oxygen specie, haemolysis, increased synthesis of pro inflammatory cytokines among others. Inflammatory process play a major function in the activation of acute painful vaso-occlusion crisis that forms the main reason for the hospitalization of patients with sickle cell anaemia. Inflammatory processes, are key components of several complications of the disease including autosplenectomy, acute chest syndrome, pulmonary hypertension, leg ulcer, nephropathy and stroke and also ultimately initiates painful vaso-occlusion episodes that characterize Sickle Cell Disease. This study titled “Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia in Crises, aims at finding out the recent updates on interferon gamma; a pro-inflammatory cytokine that plays a central role in inflammation and auto-immunity, and CRP; an acute phase protein used as a marker of inflammation in sickle cell anaemia patients in crisis. A lot of search engines were consulted in the course of writing this review such as scopus, Pubmed Central, Web of Science, Semantics, Google Scholar, Researchgate, Academia Edu, etc. Previous studies have suggested that levels of pro-inflammatory cytokines vary between steady-state and crisis states in SCA patients, hypothesized to help monitor clinical progression of the disease. . Newer therapies that target pathways downstream of the sickle are considered better options. This knowledge may have implications for the development of new treatments for sickle cell disease.
dc.description.sponsorshipKampala International University, Uganda.
dc.identifier.issn2254-609X
dc.identifier.urihttp://hdl.handle.net/20.500.12493/14519
dc.language.isoen
dc.publisherJournal of Biomedical Sciences
dc.titleAn Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia Crisis
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
an-update-on-interferon-gamma-and-c-reactive-proteins-in-sickle-cell-anaemia-crisis.pdf
Size:
300.53 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Bachelor of Clinical Medicine and Community Health(BCM)